Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Cover
- Cover Page
Financial Statements
Notes to Financial Statements
Notes Tables
Notes Details

SUBSEQUENT EVENT

SUBSEQUENT EVENT	6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENT	12.SUBSEQUENT EVENT On July 2, 2021, the Company issued to Aspire Capital Fund, LLC 200,000 Common Shares for proceeds of $329 pursuant to December 23, 2019 common share purchase agreement.

SUBSEQUENT EVENT

6 Months Ended

Jun. 30, 2021

Subsequent Events [Abstract]

SUBSEQUENT EVENT

12.SUBSEQUENT EVENT

On July 2, 2021, the Company issued to Aspire Capital Fund, LLC 200,000 Common Shares for proceeds of $329 pursuant to December 23, 2019 common share purchase agreement.